Browsing Clinical Studies by subject "Fulvestrant"
Now showing items 1-1 of 1
Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer. (2018-03)CDK4/6 inhibition substantially improves progression-free survival (PFS) for women with advanced estrogen receptor-positive breast cancer, although there are no predictive biomarkers. Early changes in circulating tumor DNA ...